Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
Stefania Lamon‐Fava, Jisun So, David Mischoulon, Thomas R. Ziegler, Boadie W. Dunlop, Becky Kinkead, Pamela J. Schettler, Andrew A. Nierenberg, Jennifer C. Felger, Krishna Rao Maddipati, Maurizio Fava, Mark Hyman Rapaport
Topics & Concepts
Eicosapentaenoic acidPlaceboInflammationMajor depressive disorderInternal medicineArachidonic acidEndocrinologyMedicinePharmacologyChemistryFatty acidPolyunsaturated fatty acidBiochemistryEnzymePathologyAlternative medicineAmygdalaFatty Acid Research and HealthTryptophan and brain disordersEicosanoids and Hypertension Pharmacology